21.39
price up icon2.05%   0.43
after-market After Hours: 21.31 -0.08 -0.37%
loading
Catalyst Pharmaceuticals Inc stock is traded at $21.39, with a volume of 959.62K. It is up +2.05% in the last 24 hours and up +9.58% over the past month. Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
See More
Previous Close:
$20.96
Open:
$21.21
24h Volume:
959.62K
Relative Volume:
0.66
Market Cap:
$2.62B
Revenue:
$460.48M
Net Income/Loss:
$142.80M
P/E Ratio:
18.13
EPS:
1.18
Net Cash Flow:
$221.79M
1W Performance:
+1.81%
1M Performance:
+9.58%
6M Performance:
-8.78%
1Y Performance:
-0.33%
1-Day Range:
Value
$21.04
$21.52
1-Week Range:
Value
$20.66
$21.55
52-Week Range:
Value
$19.05
$26.58

Catalyst Pharmaceuticals Inc Stock (CPRX) Company Profile

Name
Name
Catalyst Pharmaceuticals Inc
Name
Phone
(305) 529-2522
Name
Address
355 ALHAMBRA CIRCLE, CORAL GABLES
Name
Employee
167
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
CPRX's Discussions on Twitter

Compare CPRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CPRX
Catalyst Pharmaceuticals Inc
21.39 2.57B 460.48M 142.80M 221.79M 1.18
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
420.17 108.04B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
478.58 60.75B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
585.31 61.26B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
829.83 50.32B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
164.02 33.75B 398.11M -1.03B -868.57M -5.7032

Catalyst Pharmaceuticals Inc Stock (CPRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-04-25 Initiated Robert W. Baird Outperform
Nov-18-24 Initiated Stephens Overweight
Mar-14-24 Initiated Citigroup Buy
Mar-07-24 Initiated BofA Securities Buy
Dec-21-23 Initiated Oppenheimer Outperform
Aug-24-22 Downgrade ROTH Capital Buy → Neutral
Sep-21-18 Initiated Cantor Fitzgerald Overweight
Sep-07-18 Resumed Piper Jaffray Overweight
Oct-05-16 Upgrade Piper Jaffray Neutral → Overweight
Apr-26-16 Downgrade Piper Jaffray Overweight → Neutral
Sep-30-14 Reiterated ROTH Capital Buy
Sep-16-14 Reiterated ROTH Capital Buy
Sep-15-14 Reiterated H.C. Wainwright Buy
Oct-21-13 Reiterated Aegis Capital Buy
Sep-24-13 Initiated Maxim Group Buy
Sep-06-13 Reiterated Aegis Capital Buy
Apr-18-13 Initiated Aegis Capital Buy
Aug-27-12 Upgrade Rodman & Renshaw Mkt Perform → Mkt Outperform
Oct-01-09 Upgrade Merriman Sell → Neutral
May-29-09 Downgrade Hapoalim Neutral → Underperform
May-29-09 Downgrade Merriman Curhan Ford Buy → Sell
Dec-15-08 Initiated Merriman Curhan Ford Buy
Nov-28-07 Initiated Rodman & Renshaw Mkt Outperform
Jan-31-07 Initiated Stifel Nicolaus Buy
Jan-05-07 Initiated First Albany Buy
View All

Catalyst Pharmaceuticals Inc Stock (CPRX) Latest News

pulisher
12:10 PM

Applying Elliott Wave Theory to Catalyst Pharmaceuticals Inc.July 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com

12:10 PM
pulisher
09:37 AM

Why Catalyst Pharmaceuticals Inc. stock is favored by pension fundsJuly 2025 Highlights & Consistent Growth Equity Picks - newser.com

09:37 AM
pulisher
09:13 AM

Can Catalyst Pharmaceuticals Inc. (CN2) stock surprise with quarterly resultsMarket Trend Review & Community Verified Watchlist Alerts - newser.com

09:13 AM
pulisher
08:52 AM

Is Catalyst Pharmaceuticals Inc. stock bottoming outMarket Risk Report & Community Trade Idea Sharing Platform - newser.com

08:52 AM
pulisher
08:16 AM

Catalyst Pharmaceuticals Inc. recovery potential after sell offJuly 2025 Chart Watch & Daily Market Momentum Tracking - newser.com

08:16 AM
pulisher
08:11 AM

Price momentum metrics for Catalyst Pharmaceuticals Inc. explained2025 Price Action Summary & Safe Swing Trade Setup Alerts - newser.com

08:11 AM
pulisher
03:45 AM

Can Catalyst Pharmaceuticals Inc. hit a new high this monthPortfolio Risk Report & Free Expert Verified Stock Movement Alerts - newser.com

03:45 AM
pulisher
03:21 AM

Will Catalyst Pharmaceuticals Inc. (CN2) stock sustain uptrend momentumMarket Trend Report & High Return Trade Guides - newser.com

03:21 AM
pulisher
12:28 PM

How rising interest rates impact Catalyst Pharmaceuticals Inc. stockMarket Activity Summary & AI Optimized Trading Strategy Guides - newser.com

12:28 PM
pulisher
Oct 26, 2025

Is Catalyst Pharmaceuticals Inc. (CN2) stock attractive post correction2025 Dividend Review & Stepwise Trade Execution Plans - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Why global investors buy Catalyst Pharmaceuticals Inc. (CN2) stockQuarterly Profit Review & Verified Momentum Watchlists - newser.com

Oct 26, 2025

Catalyst Pharmaceuticals Inc Stock (CPRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Catalyst Pharmaceuticals Inc Stock (CPRX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Elsbernd Brian
Chief Compliance/Legal Officer
Sep 08 '25
Sale
20.30
30,000
609,000
271,039
$37.26
price up icon 0.00%
$93.08
price up icon 1.97%
$29.03
price down icon 2.88%
$106.05
price up icon 0.37%
biotechnology ONC
$315.43
price up icon 1.49%
$164.02
price up icon 2.73%
Cap:     |  Volume (24h):